Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Oscient Pharmaceuticals Corporation

http://

Latest From Oscient Pharmaceuticals Corporation

Pharma’s Digital Pathology Build-Out; Part 2 – What It Means

Both providers and users of digital pathology are confident that clinical use cases and the evidence needed to assure payers and encourage investment by commercial labs will overcome challenges around access and adoption.

Diagnostics Artificial Intelligence

Pharma’s Digital Pathology Build-Out; Part 1 – The State Of Play

Pharma companies are applying digital pathology throughout their research and development functions. Where are they now finding value?

Artificial Intelligence Diagnostic Imaging

Intel Speaks On Changing Radiology Workflows, Managing IT Upgrades And COVID-19 Lessons

Phillipa Chick, global account director in Intel’s health and life sciences division, laid out the case for decentralizing radiology workflows, and how companies need to educate, rather than convince, bodies like the UK’s NHS in the post-COVID landscape.

Innovation Platform Technologies

F2G Plans Orphan Drug Strategy With Novel Antifungal

Olorofim employs a novel mechanism of action within the antifungal space and was tested in patients with high mortality risk who had exhausted treatment options.

Clinical Trials Business Strategies
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
UsernamePublicRestriction

Register